$1.41 Billion is the total value of Perceptive Advisors's 199 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 60.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | NEUROCRINE BIOSCIENCES | $128,349,000 | +2.4% | 3,316,523 | +33.9% | 9.13% | +12.8% |
| TSRO | Buy | TESARO | $92,521,000 | +35.3% | 687,993 | +0.8% | 6.58% | +49.0% |
| FOLD | Buy | AMICUS THERAPEUTICS | $85,964,000 | -17.7% | 17,296,672 | +22.5% | 6.11% | -9.3% |
| SRPT | Sell | SAREPTA THERAPEUTICS | $75,976,000 | -63.6% | 2,769,829 | -18.4% | 5.40% | -59.9% |
| VSAR | Buy | VERSARTIS | $61,889,000 | +25.4% | 4,153,685 | +3.1% | 4.40% | +38.1% |
| RTRX | Buy | RETROPHIN | $50,872,000 | -7.1% | 2,687,412 | +9.8% | 3.62% | +2.4% |
| NXTM | Buy | NXSTAGE MEDICAL | $50,533,000 | +21.1% | 1,927,989 | +15.5% | 3.59% | +33.4% |
| XNCR | Buy | XENCOR | $46,982,000 | +28.2% | 1,785,018 | +19.3% | 3.34% | +41.3% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS | $45,213,000 | -16.0% | 3,128,978 | +34.1% | 3.22% | -7.4% |
| EGRX | Sell | EAGLE PHARMACEUTICALS | $39,527,000 | +1317466.7% | 498,198 | -8.5% | 2.81% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS | $34,219,000 | +210.7% | 1,260,847 | +193.2% | 2.43% | +242.2% |
| ARDX | Buy | ARDELYX | $26,073,000 | +90.6% | 1,836,196 | +73.7% | 1.85% | +110.0% |
| LBIO | LION BIOTECHNOLOGIES INC | $24,794,000 | -15.6% | 3,567,553 | 0.0% | 1.76% | -7.0% | |
| RGNX | REGENXBIO | $23,786,000 | +32.4% | 1,282,286 | 0.0% | 1.69% | +45.8% | |
| CLCD | Buy | COLUCID PHARMACEUTICALS | $23,346,000 | +10.9% | 641,364 | +16.2% | 1.66% | +22.1% |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL | $23,127,000 | -26.5% | 1,319,274 | -0.3% | 1.64% | -19.0% |
| AVXS | Buy | AVEXIS | $22,602,000 | +188.7% | 473,531 | +149.2% | 1.61% | +218.2% |
| DBVT | Buy | DBV TECHNOLOGIES ADR REPRESENTING 0.5 | $21,452,000 | +4.8% | 610,643 | +8.4% | 1.52% | +15.4% |
| GLPG | New | GALAPAGOS ADR REPRESENTING | $20,631,000 | – | 304,531 | +100.0% | 1.47% | – |
| VBIV | Buy | VBI VACCINES | $20,354,000 | +94.0% | 6,565,843 | +114.7% | 1.45% | +113.7% |
| WVE | Sell | WAVE LIFE SCIENCES | $18,088,000 | -18.5% | 665,198 | -2.7% | 1.29% | -10.2% |
| ANIP | Buy | ANI PHARMACEUTICALS | $16,192,000 | +2011.1% | 267,100 | +2210.4% | 1.15% | +2202.0% |
| XLRN | Buy | ACCELERON PHARMA | $15,822,000 | -25.9% | 619,987 | +5.1% | 1.12% | -18.4% |
| FOMX | Sell | FOAMIX PHARMACEUTICALS | $14,685,000 | +15.5% | 1,322,994 | -3.7% | 1.04% | +27.2% |
| AVDL | New | AVADEL PHARMACEUTICALS | $14,424,000 | – | 1,388,240 | +100.0% | 1.03% | – |
| ACRX | ACELRX PHARMACEUTICALS | $14,063,000 | -33.2% | 5,408,728 | 0.0% | 1.00% | -26.4% | |
| QTNT | Buy | QUOTIENT | $13,815,000 | -33.9% | 2,854,486 | +6.8% | 0.98% | -27.2% |
| ACOR | New | ACORDA THERAPEUTICS | $13,536,000 | – | 720,000 | +100.0% | 0.96% | – |
| ZYNE | Sell | ZYNERBA PHARMACEUTICALS | $13,128,000 | +15.8% | 842,128 | -3.1% | 0.93% | +27.6% |
| KDMN | KADMON | $11,821,000 | -27.1% | 2,209,657 | 0.0% | 0.84% | -19.7% | |
| CRBP | Sell | CORBUS PHARMACEUTICALS HOLDINGS INC | $10,562,000 | -42.4% | 1,250,000 | -53.7% | 0.75% | -36.6% |
| IRTC | New | IRHYTHM TECHNOLOGIES | $10,567,000 | – | 352,241 | +100.0% | 0.75% | – |
| ALDX | ALDEYRA THERAPEUTICS | $10,381,000 | -31.6% | 1,940,458 | 0.0% | 0.74% | -24.6% | |
| CTMX | New | CYTOMX THERAPEUTICS | $10,152,000 | – | 923,763 | +100.0% | 0.72% | – |
| RDUS | Sell | RADIUS HEALTH | $10,035,000 | -40.8% | 263,872 | -15.8% | 0.71% | -34.8% |
| DERM | Sell | DERMIRA | $9,875,000 | -11.9% | 325,583 | -1.8% | 0.70% | -3.0% |
| NERV | MINERVA NEUROSCIENCES INC | $9,523,000 | -16.8% | 810,537 | 0.0% | 0.68% | -8.3% | |
| ZGNX | Buy | ZOGENIX | $9,149,000 | +4215.6% | 752,999 | +3961.3% | 0.65% | +4550.0% |
| ANI PHARMACEUTICALS INC 01DEC19 3.0PCTnote | $8,700,000 | -6.2% | 7,500,000 | 0.0% | 0.62% | +3.3% | ||
| ASMB | Sell | ASSEMBLY BIOSCIENCES | $8,679,000 | +54.8% | 714,354 | -8.1% | 0.62% | +70.4% |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $8,420,000 | – | 1,330,240 | +100.0% | 0.60% | – |
| PFNX | Sell | PFENEX | $8,293,000 | -1.4% | 914,376 | -2.7% | 0.59% | +8.7% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS | $8,181,000 | -6.4% | 163,255 | -2.0% | 0.58% | +3.2% |
| MYOK | Sell | MYOKARDIA | $8,089,000 | -22.0% | 624,694 | -1.6% | 0.58% | -14.2% |
| CDTX | CIDARA THERAPEUTICS | $8,043,000 | -9.2% | 773,369 | 0.0% | 0.57% | 0.0% | |
| ALDR | Sell | ALDER BIOPHARMACEUTICALS | $7,991,000 | -37.7% | 384,169 | -1.8% | 0.57% | -31.4% |
| BPMC | Sell | BLUEPRINT MEDICINES | $7,680,000 | -43.8% | 273,820 | -40.5% | 0.55% | -38.1% |
| CLVS | Sell | CLOVIS ONCOLOGY | $7,452,000 | +20.5% | 167,754 | -2.2% | 0.53% | +32.8% |
| QURE | Sell | UNIQURE | $7,089,000 | -29.4% | 1,265,963 | -3.6% | 0.50% | -22.2% |
| ATRS | Buy | ANTARES PHARMA | $6,797,000 | +645.3% | 2,917,253 | +100.0% | 0.48% | +718.6% |
| CLSD | Buy | CLEARSIDE BIOMEDICAL | $6,365,000 | -42.2% | 712,062 | +12.2% | 0.45% | -36.3% |
| VRTX | Sell | VERTEX PHARMACEUTICALS | $6,299,000 | -32.5% | 85,509 | -20.1% | 0.45% | -25.6% |
| NEPT | Sell | NEPTUNE TECHNOLOGIES AND BIORESOURCES | $6,004,000 | -16.1% | 6,519,634 | -3.4% | 0.43% | -7.6% |
| FWP | Sell | FORWARD PHARMA ADR REPRESENTING 1 | $5,918,000 | -30.3% | 394,241 | -2.5% | 0.42% | -23.2% |
| XENE | Sell | XENON PHARMACEUTICALS | $5,700,000 | -7.8% | 740,272 | -3.0% | 0.40% | +1.5% |
| JAZZ | New | JAZZ PHARMACEUTICALS | $5,670,000 | – | 52,000 | +100.0% | 0.40% | – |
| AKBA | Sell | AKEBIA THERAPEUTICS | $5,593,000 | -23.3% | 537,256 | -33.6% | 0.40% | -15.5% |
| CSU | Sell | CAPITAL SENIOR LIVING | $5,222,000 | -17.2% | 320,173 | -14.7% | 0.37% | -8.8% |
| EVH | Sell | EVOLENT HEALTH CLASS A | $4,555,000 | -56.8% | 307,800 | -28.1% | 0.32% | -52.4% |
| BIO | Buy | BIO RAD LABORATORIES CLASS A | $4,451,000 | +171.7% | 24,416 | +144.2% | 0.32% | +199.1% |
| ALNY | New | ALNYLAM PHARMACEUTICALS | $4,436,000 | – | 118,475 | +100.0% | 0.32% | – |
| ABEO | Sell | ABEONA THERAPEUTICS | $4,085,000 | -49.0% | 842,173 | -37.0% | 0.29% | -43.9% |
| PPHMP | New | PEREGRINE PHARMACEUTICALS INC 10.5 | $3,982,000 | – | 200,000 | +100.0% | 0.28% | – |
| NVTA | New | INVITAE | $3,970,000 | – | 500,000 | +100.0% | 0.28% | – |
| PSDV | Sell | PSIVIDA | $3,898,000 | -49.3% | 2,279,706 | -10.7% | 0.28% | -44.2% |
| ABEOW | ABEONA THERAPEUTICS CW-19warrants | $3,778,000 | -7.7% | 1,259,636 | 0.0% | 0.27% | +1.9% | |
| AGRX | Sell | AGILE THERAPEUTICS | $3,770,000 | -47.1% | 661,446 | -35.2% | 0.27% | -41.7% |
| ONS | ONCOBIOLOGICS | $3,759,000 | -29.2% | 1,248,990 | 0.0% | 0.27% | -22.2% | |
| ADMA | Sell | ADMA BIOLOGICS | $3,692,000 | -30.7% | 721,102 | -1.9% | 0.26% | -23.5% |
| COLL | New | COLLEGIUM PHARMACEUTICAL | $3,063,000 | – | 196,728 | +100.0% | 0.22% | – |
| CELG | New | CELGENE | $3,010,000 | – | 26,000 | +100.0% | 0.21% | – |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS | $2,986,000 | +508.1% | 490,300 | +450.1% | 0.21% | +562.5% |
| HSGX | HISTOGENCIS CORP | $2,968,000 | -48.0% | 1,777,777 | 0.0% | 0.21% | -42.7% | |
| MYOV | New | MYOVANT SCIENCES | $2,815,000 | – | 226,322 | +100.0% | 0.20% | – |
| MGCD | MGC DIAGNOSTICS | $2,602,000 | +14.4% | 329,733 | 0.0% | 0.18% | +25.9% | |
| RARX | New | RA PHARMACEUTICALS | $2,506,000 | – | 165,000 | +100.0% | 0.18% | – |
| SELB | Sell | SELECTA BIOSCIENCES | $2,433,000 | -51.0% | 141,875 | -59.2% | 0.17% | -45.9% |
| APVO | APTEVO THERAPEUTICS | $2,411,000 | -4.7% | 988,133 | 0.0% | 0.17% | +4.9% | |
| CASC | New | CASCADIAN THERAPEUTICS | $2,355,000 | – | 546,498 | +100.0% | 0.17% | – |
| ABT | Buy | ABBOTT LABORATORIES | $1,921,000 | -1.3% | 50,000 | +8.7% | 0.14% | +8.7% |
| AERI | Sell | AERIE PHARMACEUTICALS | $1,893,000 | -87.7% | 50,000 | -87.7% | 0.14% | -86.4% |
| ATRC | Buy | ATRICURE | $1,847,000 | +1365.9% | 94,400 | +1087.6% | 0.13% | +1537.5% |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS | $1,836,000 | +5.6% | 157,679 | +21.4% | 0.13% | +17.0% |
| PFE | New | PFIZER | $1,786,000 | – | 55,000 | +100.0% | 0.13% | – |
| TXMD | New | THERAPEUTICSMD | $1,731,000 | – | 300,000 | +100.0% | 0.12% | – |
| AVEO | AVEO PHARMACEUTICALS | $1,678,000 | -39.3% | 3,108,808 | 0.0% | 0.12% | -33.5% | |
| GNMX | New | AEVI GENOMIC MEDICINE | $1,520,000 | – | 293,460 | +100.0% | 0.11% | – |
| AFMD | AFFIMED | $1,322,000 | -35.2% | 734,301 | 0.0% | 0.09% | -28.8% | |
| ARWR | ARROWHEAD Pharmaceuticals | $1,313,000 | -78.9% | 847,458 | 0.0% | 0.09% | -76.9% | |
| Sell | NEURODERM | $1,284,000 | -73.7% | 57,825 | -78.1% | 0.09% | -71.1% | |
| ALQA | ALLIQUA BIOMEDICAL | $1,133,000 | -26.3% | 1,921,951 | 0.0% | 0.08% | -18.2% | |
| AZRX | New | AZURRX BIOPHARMA | $1,077,000 | – | 227,272 | +100.0% | 0.08% | – |
| MDCO | New | MEDICINES CO PUT 32 04/21/2017put | $1,070,000 | – | 200,000 | +100.0% | 0.08% | – |
| VXX | New | BARCLAYS BANK IPATH SandP 500 VIX SHORT TERM FUTURES ETN EXP | $1,046,000 | – | 41,000 | +100.0% | 0.07% | – |
| BCLI | New | BRAINSTORM CELL THERAPEUTICS | $1,016,000 | – | 400,000 | +100.0% | 0.07% | – |
| CSBR | CHAMPIONS ONCOLOGY | $942,000 | +50.7% | 372,597 | 0.0% | 0.07% | +67.5% | |
| ARNI | ARNO THERAPEUTICS INC | $781,000 | -60.2% | 4,177,577 | 0.0% | 0.06% | -55.9% | |
| QHCCQ | New | QUORUM HEALTH | $731,000 | – | 100,604 | +100.0% | 0.05% | – |
| ACHI | Buy | ACCRETIVE HEALTH | $709,000 | +132.5% | 315,000 | +152.0% | 0.05% | +150.0% |
| WCG | WELLCARE HEALTHCARE PLANS | $693,000 | +17.1% | 5,056 | 0.0% | 0.05% | +28.9% | |
| EXEL | New | EXELIXIS | $691,000 | – | 46,361 | +100.0% | 0.05% | – |
| UTHR | UNITED THERAPEUTICS | $682,000 | +21.6% | 4,753 | 0.0% | 0.05% | +33.3% | |
| AMAG | AMAG PHARMACEUTICALS | $679,000 | +41.8% | 19,524 | 0.0% | 0.05% | +54.8% | |
| EXAS | New | EXACT SCIENCES CORP PUT 17 01/20/2017put | $670,000 | – | 200,000 | +100.0% | 0.05% | – |
| INCR | INC RESEARCH HOLDINGS CLASS A | $665,000 | +18.1% | 12,636 | 0.0% | 0.05% | +30.6% | |
| PRTO | Buy | PROTEON THERAPEUTICS | $635,000 | -74.7% | 334,116 | +24.2% | 0.04% | -72.2% |
| MTST | New | METASTAT INC | $618,000 | – | 500,000 | +100.0% | 0.04% | – |
| ENZ | Buy | ENZO BIOCHEM | $582,000 | +70.2% | 83,893 | +25.0% | 0.04% | +86.4% |
| FCAU | FIAT CHRYSLER AUTOMOBILES | $565,000 | +42.3% | 62,000 | 0.0% | 0.04% | +53.8% | |
| INCY | INCYTE | $563,000 | +6.2% | 5,619 | 0.0% | 0.04% | +17.6% | |
| MGLN | Sell | MAGELLAN HEALTH | $565,000 | +20.0% | 7,508 | -14.4% | 0.04% | +33.3% |
| BIIB | Buy | BIOGEN INC | $545,000 | -9.3% | 1,922 | +0.1% | 0.04% | 0.0% |
| CCRN | New | CROSS COUNTRY HEALTHCARE | $544,000 | – | 34,819 | +100.0% | 0.04% | – |
| SCYX | SCYNEXIS | $546,000 | -17.5% | 171,185 | 0.0% | 0.04% | -9.3% | |
| HUM | Buy | HUMANA INC CALL 210 04/21/2017call | $528,000 | +0.4% | 40,000 | +9900.0% | 0.04% | +11.8% |
| ICLR | ICON | $517,000 | -2.8% | 6,873 | 0.0% | 0.04% | +8.8% | |
| ONSIZ | ONCOBIOLOGICS INC WTSw exp 2/18/2017 | $518,000 | -34.2% | 656,382 | 0.0% | 0.04% | -27.5% | |
| UNH | Sell | UNITEDHEALTH GROUP | $516,000 | +14.2% | 3,223 | -0.2% | 0.04% | +27.6% |
| TCON | New | TRACON PHARMACEUTICALS | $490,000 | – | 100,000 | +100.0% | 0.04% | – |
| AMN | Sell | AMN HEALTHCARE | $484,000 | +13.1% | 12,585 | -6.4% | 0.03% | +21.4% |
| LNTH | LANTHEUS HOLDINGS | $462,000 | +3.8% | 53,763 | 0.0% | 0.03% | +13.8% | |
| AGTC | Sell | APPLIED GENETIC TECHNOLOGIES | $470,000 | -88.7% | 50,251 | -88.2% | 0.03% | -87.7% |
| HUM | New | HUMANA | $454,000 | – | 2,227 | +100.0% | 0.03% | – |
| HRC | Sell | HILL ROM HOLDINGS | $445,000 | -25.0% | 7,930 | -17.1% | 0.03% | -15.8% |
| AGLE | AEGLEA BIOTHERAPEUTICS | $451,000 | -32.1% | 103,585 | 0.0% | 0.03% | -25.6% | |
| ESRX | New | EXPRESS SCRIPTS HOLDING | $457,000 | – | 6,639 | +100.0% | 0.03% | – |
| MCK | Buy | MCKESSON | $432,000 | -13.1% | 3,078 | +3.3% | 0.03% | -3.1% |
| NVAX | New | NOVAVAX | $423,000 | – | 335,413 | +100.0% | 0.03% | – |
| IMDZ | IMMUNE DESIGN | $428,000 | -27.3% | 77,725 | 0.0% | 0.03% | -21.1% | |
| SCMP | Sell | SUCAMPO PHARMACEUTICALS CLASS A | $416,000 | -17.8% | 30,694 | -25.3% | 0.03% | -9.1% |
| MOH | Sell | MOLINA HEALTHCARE | $379,000 | -26.8% | 6,981 | -21.4% | 0.03% | -18.2% |
| RACE | FERRARI | $360,000 | +11.8% | 6,200 | 0.0% | 0.03% | +23.8% | |
| IRIX | New | IRIDEX | $308,000 | – | 21,885 | +100.0% | 0.02% | – |
| PZRXQ | PHASERX | $310,000 | -39.7% | 200,000 | 0.0% | 0.02% | -33.3% | |
| AGEN | Sell | AGENUS | $297,000 | -95.4% | 72,187 | -92.0% | 0.02% | -95.0% |
| NVLS | NIVALIS THERAPEUTICS | $274,000 | -72.4% | 122,275 | 0.0% | 0.02% | -70.3% | |
| SRPT | New | SAREPTA THERAPEUTICS INC PUT 50 01/20/2017put | $249,000 | – | 10,900 | +100.0% | 0.02% | – |
| ACST | Sell | ACASTI PHARMA CLASS A | $233,000 | -43.7% | 186,559 | -21.1% | 0.02% | -37.0% |
| PERNIX THERAPEUTICS HOLD 01APR21 4.25PCTnote | $246,000 | -15.8% | 1,000,000 | 0.0% | 0.02% | -10.5% | ||
| PBYI | PUMA BIOTECHNOLOGY | $225,000 | -54.3% | 7,344 | 0.0% | 0.02% | -50.0% | |
| LHCG | LHC GROUP | $217,000 | +24.0% | 4,745 | 0.0% | 0.02% | +36.4% | |
| ENDP | New | ENDO INTERNATIONAL | $213,000 | – | 12,920 | +100.0% | 0.02% | – |
| NTLA | INTELLIA THERAPEUTICS | $192,000 | -23.2% | 14,673 | 0.0% | 0.01% | -12.5% | |
| MACK | MERRIMACK PHARMACEUTICALS | $200,000 | -35.7% | 48,910 | 0.0% | 0.01% | -30.0% | |
| FVE | New | FIVE STAR QUALITY CARE | $183,000 | – | 67,797 | +100.0% | 0.01% | – |
| GNVC | New | GENVEC | $180,000 | – | 56,131 | +100.0% | 0.01% | – |
| PMD | Sell | PSYCHEMEDICS | $164,000 | -34.4% | 6,626 | -47.5% | 0.01% | -25.0% |
| BOLD | AUDENTES THERAPEUTICS | $137,000 | +2.2% | 7,500 | 0.0% | 0.01% | +11.1% | |
| ONSIW | ONCOBIOLOGICS INC WTSw exp 2/18/2017 | $124,000 | -60.4% | 656,382 | 0.0% | 0.01% | -55.0% | |
| STML | STEMLINE THERAPEUTICS | $115,000 | -0.9% | 10,702 | 0.0% | 0.01% | +14.3% | |
| MDGWW | New | AEVI GENOMIC MEDICINE WARRANTwarrants | $106,000 | – | 150,000 | +100.0% | 0.01% | – |
| CYNO | CYNOSURE CLASS A | $82,000 | -10.9% | 1,800 | 0.0% | 0.01% | 0.0% | |
| CEMP | Sell | CEMPRA | $62,000 | -98.5% | 22,321 | -87.3% | 0.00% | -98.5% |
| CBPO | Sell | CHINA BIOLOGIC PRODUCTS | $25,000 | -98.5% | 236 | -98.3% | 0.00% | -98.2% |
| OPHT | New | OPHTHOTECH CORP PUT 20 01/20/2017put | $24,000 | – | 1,600 | +100.0% | 0.00% | – |
| RXDX | Sell | IGNYTA | $35,000 | -98.4% | 6,584 | -98.1% | 0.00% | -98.6% |
| VCEL | Sell | VERICEL | $28,000 | -98.2% | 9,385 | -98.3% | 0.00% | -98.0% |
| GKOS | Sell | GLAUKOS | $10,000 | -95.0% | 300 | -94.3% | 0.00% | -92.3% |
| WST | New | WEST PHARMACEUTICAL SERVICES | $12,000 | – | 138 | +100.0% | 0.00% | – |
| INGN | INOGEN | $8,000 | +14.3% | 125 | 0.0% | 0.00% | – | |
| CAPR | CAPRICOR THERAPEUTICS | $11,000 | -15.4% | 4,000 | 0.0% | 0.00% | 0.0% | |
| SEVION THERAPEUTICS INC | $8,000 | -20.0% | 59,220 | 0.0% | 0.00% | 0.0% | ||
| BMRN | BIOMARIN PHARMACEUTICAL | $21,000 | -8.7% | 250 | 0.0% | 0.00% | 0.0% | |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS | $11,000 | -99.8% | 421 | -99.8% | 0.00% | -99.7% |
| ARIA | New | ARIAD PHARMACEUTICALS | $19,000 | – | 1,551 | +100.0% | 0.00% | – |
| PPHM | PEREGRINE PHARMACEUTICALS | $8,000 | -20.0% | 24,332 | 0.0% | 0.00% | 0.0% | |
| ABMD | Sell | ABIOMED | $12,000 | -99.9% | 109 | -99.8% | 0.00% | -99.8% |
| TNGNQ | TENGION INC | $1,000 | 0.0% | 1,826,399 | 0.0% | 0.00% | – | |
| OPHT | Sell | OPHTHOTECH CORP CALL 75 01/20/2017call | $5,000 | -99.8% | 220,400 | -63.3% | 0.00% | -100.0% |
| NEOS | Sell | NEOS THERAPEUTICS | $6,000 | -99.7% | 1,056 | -99.7% | 0.00% | -100.0% |
| MRTX | New | MIRATI THERAPEUTICS | $2,000 | – | 521 | +100.0% | 0.00% | – |
| LLY | Buy | ELI LILLY & CO CALL 90 01/20/2017call | $3,000 | -98.8% | 100,000 | +9900.0% | 0.00% | -100.0% |
| JNJ | New | JOHNSON and JOHNSON | $0 | – | 2 | +100.0% | 0.00% | – |
| IWS | New | ISHARES RUSSELL MID-CAP VALUE ETF | $0 | – | 2 | +100.0% | 0.00% | – |
| GLD | New | SPDR GOLD SHARES ETF | $0 | – | 1 | +100.0% | 0.00% | – |
| XBI | New | SPDR SandP BIOTECH ETF | $3,000 | – | 50 | +100.0% | 0.00% | – |
| DIA | New | SPDR DOW JONES INDUSTRIAL AVERAGE ETF | $1,000 | – | 3 | +100.0% | 0.00% | – |
| SGMO | SANGAMO BIOSCIENCES | $1,000 | 0.0% | 272 | 0.0% | 0.00% | – | |
| TLT | New | ISHARES 20 PLUS YEAR TREASURY BOND ETFnote | $0 | – | 2 | +100.0% | 0.00% | – |
| IVV | New | ISHARES CORE SandP 500 ETF | $0 | – | 1 | +100.0% | 0.00% | – |
| IPXL | New | IMPAX LABORATORIES | $0 | – | 1 | +100.0% | 0.00% | – |
| TMO | New | THERMO FISHER SCIENTIFIC | $0 | – | 2 | +100.0% | 0.00% | – |
| FLKS | FLEX PHARMA | $1,000 | -66.7% | 237 | 0.0% | 0.00% | – | |
| DVAX | New | DYNAVAX TECHNOLOGIES CALL 4 01/2017call | $5,000 | – | 15,600 | +100.0% | 0.00% | – |
| DVA | New | DAVITA | $0 | – | 3 | +100.0% | 0.00% | – |
| DHR | New | DANAHER | $0 | – | 3 | +100.0% | 0.00% | – |
| CRY | CRYOLIFE | $2,000 | 0.0% | 123 | 0.0% | 0.00% | – | |
| CRBP | New | CORBUS PHARMACEUTICALS HOLDINGS INC CALL 15 01/20/2017call | $0 | – | 1,600 | +100.0% | 0.00% | – |
| ZTS | New | ZOETIS CLASS A | $0 | – | 3 | +100.0% | 0.00% | – |
| CTLT | New | CATALENT | $0 | – | 3 | +100.0% | 0.00% | – |
| INNL | Sell | INNOCOLL | $7,000 | -99.8% | 9,433 | -98.3% | 0.00% | -100.0% |
| BRKR | New | BRUKER | $0 | – | 3 | +100.0% | 0.00% | – |
| BSX | New | BOSTON SCIENTIFIC | $0 | – | 3 | +100.0% | 0.00% | – |
| AVGR | AVINGER | $4,000 | -20.0% | 1,062 | 0.0% | 0.00% | – | |
| NPCUF | ALLON THERAPEUTICS | $0 | – | 751,124 | 0.0% | 0.00% | – | |
| ACAD | New | ACADIA PHARMACEUTICALS INC CALL 40 01/20/2017call | $7,000 | – | 100,000 | +100.0% | 0.00% | – |
| MD | Exit | MEDNAX INC | $0 | – | -29 | -100.0% | 0.00% | – |
| DSCI | Exit | DERMA SCIENCES INC | $0 | – | -2,970 | -100.0% | -0.00% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -5,343 | -100.0% | -0.00% | – |
| ACETQ | Exit | ACETO CORP | $0 | – | -6,054 | -100.0% | -0.01% | – |
| DRAD | Exit | DIGIRAD CORP | $0 | – | -24,988 | -100.0% | -0.01% | – |
| HNGR | Exit | HANGER INC | $0 | – | -15,038 | -100.0% | -0.01% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -200 | -100.0% | -0.01% | – |
| IVC | Exit | INVACARE CORP | $0 | – | -13,200 | -100.0% | -0.01% | – |
| MDSO | Exit | MEDIDATA SOLUTIONS INC | $0 | – | -2,865 | -100.0% | -0.01% | – |
| MTD | Exit | METTLER TOLEDO INTERNATIONAL | $0 | – | -415 | -100.0% | -0.01% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -2,589 | -100.0% | -0.01% | – |
| AMRI | Exit | ALBANY MOLECULAR RESEARCH | $0 | – | -10,300 | -100.0% | -0.01% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -27,300 | -100.0% | -0.01% | – |
| CGNT | Exit | COGENTIX MEDICAL INC | $0 | – | -99,008 | -100.0% | -0.01% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -10,518 | -100.0% | -0.01% | – |
| BVX | Exit | BOVIE MEDICAL CORP | $0 | – | -48,544 | -100.0% | -0.02% | – |
| GNVC | Exit | GENVEC INC | $0 | – | -561,320 | -100.0% | -0.02% | – |
| TDOC | Exit | TELADOC INC | $0 | – | -15,000 | -100.0% | -0.02% | – |
| MNKKQ | Exit | MALLINCKRODT PLC | $0 | – | -4,500 | -100.0% | -0.02% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -16,200 | -100.0% | -0.02% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -3,400 | -100.0% | -0.03% | – |
| Q | Exit | QUINTILES IMS HOLDINGS INC | $0 | – | -5,103 | -100.0% | -0.03% | – |
| KND | Exit | KINDRED HEATHCARE INC | $0 | – | -42,301 | -100.0% | -0.03% | – |
| AFAM | Exit | ALMOST FAMILY INC | $0 | – | -11,942 | -100.0% | -0.03% | – |
| AMSG | Exit | AMSURG CORP | $0 | – | -6,618 | -100.0% | -0.03% | – |
| CRL | Exit | CHARLES RIVER LABORATORIES | $0 | – | -5,482 | -100.0% | -0.03% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -6,202 | -100.0% | -0.03% | – |
| UHS | Exit | UNIVERSAL HEALTH SERVICES CLASS B | $0 | – | -3,989 | -100.0% | -0.03% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -6,398 | -100.0% | -0.03% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -10,540 | -100.0% | -0.03% | – |
| AET | Exit | AETNA INC | $0 | – | -4,454 | -100.0% | -0.03% | – |
| VWR | Exit | VWR CORP | $0 | – | -18,657 | -100.0% | -0.03% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -6,500 | -100.0% | -0.03% | – |
| LH | Exit | LABORATORY CORPORATION OF AMERICA HOLDINGS | $0 | – | -3,990 | -100.0% | -0.04% | – |
| WOOF | Exit | VCA INC | $0 | – | -7,940 | -100.0% | -0.04% | – |
| HWAY | Exit | HEALTHWAYS INC | $0 | – | -21,608 | -100.0% | -0.04% | – |
| PAHC | Exit | PHIBRO ANIMAL HEALTH CLASS A | $0 | – | -24,300 | -100.0% | -0.04% | – |
| LCI | Exit | LANNETT COMPANY INC | $0 | – | -26,670 | -100.0% | -0.05% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICS | $0 | – | -400,000 | -100.0% | -0.06% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -11,746 | -100.0% | -0.08% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -94,236 | -100.0% | -0.10% | – |
| MDGN | Exit | MEDGENICS INC | $0 | – | -293,460 | -100.0% | -0.11% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -65,240 | -100.0% | -0.13% | – |
| MYL | Exit | MYLAN NV | $0 | – | -94,711 | -100.0% | -0.23% | – |
| BGNE | Exit | BEIGENE LTDdepository receipt | $0 | – | -132,057 | -100.0% | -0.26% | – |
| CLLS | Exit | CELLECTIS ADRdepository receipt | $0 | – | -179,506 | -100.0% | -0.28% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -1,459,627 | -100.0% | -0.30% | – |
| AMRN | Exit | AMARIN CORP PLC-ADRdepository receipt | $0 | – | -1,622,280 | -100.0% | -0.33% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS INC | $0 | – | -344,550 | -100.0% | -0.35% | – |
| CASC | Exit | CASCADIAN THERAPEUTICS INC | $0 | – | -3,414,121 | -100.0% | -0.36% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP SHS PUT 12 12/16/2016put | $0 | – | -16,000 | -100.0% | -0.46% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS | $0 | – | -929,290 | -100.0% | -0.49% | – |
| Exit | CYTOMX THERAPEUTICS, INCpreferred stock | $0 | – | -742,021 | -100.0% | -0.75% | – | |
| DEPO | Exit | DEPOMED INC | $0 | – | -535,000 | -100.0% | -0.86% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -178,849 | -100.0% | -1.01% | – |
| FLML | Exit | FLAMEL TECHNOLOGIES -SP ADRdepository receipt | $0 | – | -1,363,711 | -100.0% | -1.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2017-05-02
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.